potassium citrate · Medicine question

What does the product information say about pharmaceutical incompatibilities for Renodyra 1080 mg potassium citrate modified-release tablets?

Name: What does the product information say about pharmaceutical incompatibilities for Renodyra 1080 mg potassium citrate modified-release tablets?
Published: 2026-11-08T14:21:34.668Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

The product information for Renodyra 1080 mg potassium citrate modified-release tablets states that pharmaceutical incompatibilities are “Not applicable.”

Sources for this answer

Renodyra 1080 mg modified-release tabletsPenlan Pharmaceuticals Ltd · emc · SmPC §6.2 Incompatibilities · Version 1Document updated 9 January 2026

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about potassium citrate